Connect with us

Hi, what are you looking for?

CE Mark

Innovative Health Sciences Wins CE mark for Syringe Infusion System

Innovative Health Sciences announced today that it received CE mark approval in Europe for its Insignis syringe infusion system.

Innovative Health Sciences Wins CE mark for Syringe Infusion System

Innovative Health Sciences announced today that it received CE mark approval in Europe for its Insignis syringe infusion system.

Chester, N.Y.-based Innovative Health Sciences designed the Insignis syringe infusion system to offer a combination of intravenous and subcutaneous non-electric infusion for use with a selectable rate flow controller — the IV Controller and the OneSett.

According to a news release, the newly CE-marked system — which also garnered ISO 13485 quality management system certification — is the first combination of such infusion methods.

Insignis, used for intravenous administration, creates a portable, non-electric, versatile, cost-effective and intuitive infusion pump option, Innovative Health Sciences said. The system accurately delivers medications from KVO up to 250mL/hour with a direct reading selectable rate flow controller.

The company said Insignis will be offered at €139 (approximately $163.91), with the OneSett offering lower cost per infusion, considering the cost of separate pieces of the ancillary supplies.

“The IHS system represents a paradigm shift in simplicity, excellence, cost effectiveness, usability and patient-centered design,” Innovative Health Sciences founder, chairman & CTO Andrew Sealfon said in the release

The post Innovative Health Sciences wins CE mark for syringe infusion system appeared first on Drug Delivery Business.

Seen on Drug Delivery Business: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

BioTechnology

Baleon Capital, a one-year-old venture capital firm started by investment veteran Jon Kaiden, closed its first fund to invest in pre-Series A and Series...

Artificial Intelligence

The Asian digital health market is expected to be worth up to $100 billion by 2025.

Digital Health

Today, BoxGroup is announcing it has beefed up its war chest so that it can be that “first yes” to more companies with the...

CE Mark

Paragonix SherpaPak® CTS is the only commercially available FDA-cleared and CE-marked medical device for heart transportation and the only device to fit small pediatric...

You May Also Like

Artificial Intelligence

Digital Solutions In Healthcare Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare industry by storm....

Digital Health

The sky’s the limit for HealthTech PR and looking past traditional strategies to nontraditional avenues for engagement will allow agencies to stand out.

COVID-19

In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...

Artificial Intelligence

Joe Mullings discusses the Microbot – Liberty robotic platform with Harel Gadot and how a new category of surgical robotics creates a new entry...